Polypid Ltd (PYPD)

Sep 30, 2025

PolyPid at Lytham Partners: Strategic Insights on D-PLEX100 By Investing.com - Investing.com Australia

Sep 30, 2025

Sep 30, 2025

PolyPid to present phase 3 SHIELD II trial results at ACS congress - Investing.com

Sep 30, 2025

Sep 30, 2025

PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress - The Manila Times

Sep 30, 2025

Sep 30, 2025

PolyPid Ltd. Announces Presentation of Phase 3 SHIELD II Trial Results at 2025 ACS Clinical Congress - Quiver Quantitative

Sep 30, 2025

Sep 30, 2025

PolyPid to Present Its Positive Phase 3 SHIELD II Topline - GlobeNewswire

Sep 30, 2025

Sep 30, 2025

Price action breakdown for PolyPid Ltd.July 2025 Snapshot & Fast Moving Stock Watchlists - newser.com

Sep 30, 2025

Sep 29, 2025

Tools to monitor PolyPid Ltd. recovery probabilityTrade Exit Summary & Capital Efficient Trading Techniques - newser.com

Sep 29, 2025

Sep 29, 2025

Will PolyPid Ltd. see short term momentumQuarterly Investment Review & Low Drawdown Momentum Ideas - newser.com

Sep 29, 2025

Sep 29, 2025

PolyPid (NASDAQ:PYPD) & Cronos Group (NASDAQ:CRON) Head to Head Survey - Defense World

Sep 29, 2025

Sep 28, 2025

What analysts say about PolyPid Ltd stockVolume Analysis Techniques & Invest Smarter With Data-Driven Models - earlytimes.in

Sep 28, 2025

Sep 28, 2025

What drives PolyPid Ltd stock priceFibonacci Retracement Levels & Free Rapid Growing Investment Returns - earlytimes.in

Sep 28, 2025

Sep 28, 2025

PolyPid Ltd. (NASDAQ:PYPD) Receives $12.40 Consensus PT from Analysts - Defense World

Sep 28, 2025

Sep 27, 2025

PolyPid (NASDAQ:PYPD) Rating Increased to Hold at Wall Street Zen - MarketBeat

Sep 27, 2025

Sep 25, 2025

What to expect from PolyPid Ltd. in the next 30 days2025 Major Catalysts & Verified High Yield Trade Plans - newser.com

Sep 25, 2025

Sep 25, 2025

PolyPid Ltd. (NASDAQ:PYPD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Sep 25, 2025

Sep 23, 2025

PolyPid (NASDAQ:PYPD) Stock Price Up 2.9%Time to Buy? - MarketBeat

Sep 23, 2025

Sep 23, 2025

PolyPid (NASDAQ:PYPD) Stock Price Up 2.9% – Time to Buy? - Defense World

Sep 23, 2025

Sep 22, 2025

Will a bounce in PolyPid Ltd. offer an exitBuy Signal & Free Daily Entry Point Trade Alerts - newser.com

Sep 22, 2025

Sep 22, 2025

PolyPid Ltd. (NASDAQ:PYPD) Short Interest Update - MarketBeat

Sep 22, 2025

Sep 21, 2025

Multi factor analysis applied to PolyPid Ltd.Exit Point & Verified High Yield Trade Plans - newser.com

Sep 21, 2025

Sep 21, 2025

Real time breakdown of PolyPid Ltd. stock performanceMarket Rally & AI Driven Price Predictions - newser.com

Sep 21, 2025

Sep 20, 2025

Does PolyPid Ltd. show high probability of reboundExit Point & Safe Entry Trade Signal Reports - newser.com

Sep 20, 2025

Sep 20, 2025

Strategies to average down on PolyPid Ltd.July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com

Sep 20, 2025

Sep 19, 2025

PolyPid completes Israeli Ministry of Health GMP inspection - MSN

Sep 19, 2025

Sep 19, 2025

PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements - MSN

Sep 19, 2025

Sep 19, 2025

Is PolyPid Ltd. forming a reversal patternRisk Management & Weekly High Return Stock Opportunities - newser.com

Sep 19, 2025

Sep 19, 2025

Decliners Report: Can PolyPid Ltd. ride the EV waveWeekly Market Report & Entry Point Strategy Guides - خودرو بانک

Sep 19, 2025

Sep 19, 2025

Applying Wyckoff theory to PolyPid Ltd. stockMarket Risk Summary & Proven Capital Preservation Methods - newser.com

Sep 19, 2025

Sep 19, 2025

Profit Review: Is now the right time to enter ATIIWJuly 2025 Pullbacks & Comprehensive Market Scan Insights - khodrobank.com

Sep 19, 2025

Sep 18, 2025

PolyPid Ltd. stock trendline breakdownJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com

Sep 18, 2025

Sep 17, 2025

Using data models to predict PolyPid Ltd. stock movement2025 Top Decliners & Safe Swing Trade Setups - newser.com

Sep 17, 2025

Sep 17, 2025

PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference - The Manila Times

Sep 17, 2025

Sep 17, 2025

PolyPid to Present at Lytham Partners Fall 2025 Investor - GlobeNewswire

Sep 17, 2025

Sep 17, 2025

Late-Stage Biopharma PolyPid Announces Double Conference Lineup: Lytham Partners and ROTH Healthcare - Stock Titan

Sep 17, 2025

Sep 17, 2025

Has PolyPid Ltd. found a price floorJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - newser.com

Sep 17, 2025

Sep 16, 2025

PolyPid Completes Key GMP Inspection for D-PLEX100 Manufacturing Readiness - TipRanks

Sep 16, 2025

Sep 16, 2025

How to use Fibonacci retracement on PolyPid Ltd.Market Growth Summary & Short-Term Trading Opportunity Alerts - newser.com

Sep 16, 2025

Sep 16, 2025

Short Squeeze: Is PolyPid Ltd. forming a breakout patternQuarterly Earnings Report & Growth Focused Investment Plans - خودرو بانک

Sep 16, 2025

Sep 16, 2025

PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection - MarketScreener

Sep 16, 2025

Sep 16, 2025

PolyPid Successfully Completes Israeli Ministry of Health - GlobeNewswire

Sep 16, 2025

Sep 16, 2025

Polypid clears Israeli health ministry GMP inspection, nears commercial manufacturing for D-PLEX - MarketScreener

Sep 16, 2025